Cellusion Inc.
PrivateLast Round
Series C
Jun 7, 2023
Total Funding Raised
$34.45M
Company Overview
Cellusion Inc. is a regenerative medicine company developing a novel cell therapy product, CLS001, for the treatment of bullous keratopathy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellusion Inc. Comparables
Compare Cellusion Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SYSTANE | 88% | |
| ActualEyes, Inc. | 84% | |
| Emmecell | 83% | |
Cellusion Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 7, 2023 | ||||
| Series B | Jan 7, 2022 | ||||
| Series A | Jan 14, 2020 | ||||
| Grant | May 31, 2019 |
Cellusion Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keio Innovation Initiative | Series B, Series A |
| UTEC (The University of Tokyo Edge Capital Partners) | Series C, Series B |
| New Energy and Industrial Technology Development Organization | Grant |
| Nissay Capital | Series C |
| JIC Venture Growth Investments | Series C |
| Toyo Seikan Group Holdings, Ltd. | Series B |
| Axil Capital Partners | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 7, 2023
$21M round led by SPARX Asset Management and Axil Capital Partners.
- Jan 7, 2022
$9.5M round led by UTEC.
Cellusion Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cellusion Inc.'s valuation, stock price, and market status.